#GastricCancer #HemOnc #BoardPrep Practice question of the week. For 1,500+ board-style hem/onc questions plus AI study tools, check out Meducation AI. Free 7-day trial: meducationai.com
November 4, 2026 at 5:08 PM
#GastricCancer #HemOnc #BoardPrep Practice question of the week. For 1,500+ board-style hem/onc questions plus AI study tools, check out Meducation AI. Free 7-day trial: meducationai.com
Two sentences can carry a lot of knowledge earned through lived experience. Smart Patients share that knowledge with the newly diagnosed.
If you or someone you love is facing stomach cancer, our community is here for you: https://ow.ly/VGQR5101NI2
#StomachCancerAwarenessMonth #GastricCancer
If you or someone you love is facing stomach cancer, our community is here for you: https://ow.ly/VGQR5101NI2
#StomachCancerAwarenessMonth #GastricCancer
November 1, 2026 at 6:45 PM
Two sentences can carry a lot of knowledge earned through lived experience. Smart Patients share that knowledge with the newly diagnosed.
If you or someone you love is facing stomach cancer, our community is here for you: https://ow.ly/VGQR5101NI2
#StomachCancerAwarenessMonth #GastricCancer
If you or someone you love is facing stomach cancer, our community is here for you: https://ow.ly/VGQR5101NI2
#StomachCancerAwarenessMonth #GastricCancer
🧪 Withaferin A is a potent and promising natural compound that induces apoptosis and ferroptosis in #GastricCancer cells through reactive oxygen species-mediated #mitochondrial damage and the Keap1/Nrf2/HO-1/GPX4 signaling pathway, respectively!
Find out more 👉 https://bit.ly/47JyuiL
Find out more 👉 https://bit.ly/47JyuiL
October 30, 2026 at 9:13 PM
🧪 Withaferin A is a potent and promising natural compound that induces apoptosis and ferroptosis in #GastricCancer cells through reactive oxygen species-mediated #mitochondrial damage and the Keap1/Nrf2/HO-1/GPX4 signaling pathway, respectively!
Find out more 👉 https://bit.ly/47JyuiL
Find out more 👉 https://bit.ly/47JyuiL
Cancer’s hidden regulators are often overlooked.
This study identifies psiTPTE22-HERV as a #TumourSuppressor in #GastricCancer, showing that its epigenetic silencing promotes disease, while low expression predicts poorer survival.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies psiTPTE22-HERV as a #TumourSuppressor in #GastricCancer, showing that its epigenetic silencing promotes disease, while low expression predicts poorer survival.
#GenesAndDiseases: doi.org/10.1016/j.ge...
November 3, 2026 at 3:54 PM
Cancer’s hidden regulators are often overlooked.
This study identifies psiTPTE22-HERV as a #TumourSuppressor in #GastricCancer, showing that its epigenetic silencing promotes disease, while low expression predicts poorer survival.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies psiTPTE22-HERV as a #TumourSuppressor in #GastricCancer, showing that its epigenetic silencing promotes disease, while low expression predicts poorer survival.
#GenesAndDiseases: doi.org/10.1016/j.ge...
Can physical activity help reduce the risk of #GastricCancer? The answer is yes!
WHO guidelines suggest adults should aim for 150-300 minutes of moderate-intensity or 75-150 minutes of vigorous-intensity aerobic activity per week for health benefits.
👉
buff.ly/IhOoFKu
WHO guidelines suggest adults should aim for 150-300 minutes of moderate-intensity or 75-150 minutes of vigorous-intensity aerobic activity per week for health benefits.
👉
buff.ly/IhOoFKu
November 3, 2026 at 9:00 AM
Can physical activity help reduce the risk of #GastricCancer? The answer is yes!
WHO guidelines suggest adults should aim for 150-300 minutes of moderate-intensity or 75-150 minutes of vigorous-intensity aerobic activity per week for health benefits.
👉
buff.ly/IhOoFKu
WHO guidelines suggest adults should aim for 150-300 minutes of moderate-intensity or 75-150 minutes of vigorous-intensity aerobic activity per week for health benefits.
👉
buff.ly/IhOoFKu
Excited to share our new preprint! A genomic 🧬 precision medicine approach for a bacterium 🦠 that lives in the stomachs of more than 40% of people worldwide. 1/n
#Helicobacterpylori #AntibioticResistance #GastricCancer #StomachCancer #Genomics #PrecisionMedicine
#Helicobacterpylori #AntibioticResistance #GastricCancer #StomachCancer #Genomics #PrecisionMedicine
October 27, 2026 at 10:20 PM
Excited to share our new preprint! A genomic 🧬 precision medicine approach for a bacterium 🦠 that lives in the stomachs of more than 40% of people worldwide. 1/n
#Helicobacterpylori #AntibioticResistance #GastricCancer #StomachCancer #Genomics #PrecisionMedicine
#Helicobacterpylori #AntibioticResistance #GastricCancer #StomachCancer #Genomics #PrecisionMedicine
#GastricCancer #HemOnc #BoardPrep Practice question of the week. Build your hem/onc board prep with 1,500+ questions and AI study tools at Meducation AI. Free 7-day trial: meducationai.com
October 30, 2026 at 4:07 PM
#GastricCancer #HemOnc #BoardPrep Practice question of the week. Build your hem/onc board prep with 1,500+ questions and AI study tools at Meducation AI. Free 7-day trial: meducationai.com
Not all cancer drivers encode proteins.
This study identifies the lncRNA SERHL as a suppressor of #GastricCancer progression, revealing its potential as a #biomarker and therapeutic target through inhibition of KLF16 signalling.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies the lncRNA SERHL as a suppressor of #GastricCancer progression, revealing its potential as a #biomarker and therapeutic target through inhibition of KLF16 signalling.
#GenesAndDiseases: doi.org/10.1016/j.ge...
November 2, 2026 at 12:01 PM
Not all cancer drivers encode proteins.
This study identifies the lncRNA SERHL as a suppressor of #GastricCancer progression, revealing its potential as a #biomarker and therapeutic target through inhibition of KLF16 signalling.
#GenesAndDiseases: doi.org/10.1016/j.ge...
This study identifies the lncRNA SERHL as a suppressor of #GastricCancer progression, revealing its potential as a #biomarker and therapeutic target through inhibition of KLF16 signalling.
#GenesAndDiseases: doi.org/10.1016/j.ge...
Symptoms of #GastricCancer can be vague and are often mistaken for less serious conditions.
These symptoms don't always mean gastric cancer, but if they persist or keep coming back, don't ignore them. Speak to your doctor.
This #GCAM2026, learn to recognise the signs.
These symptoms don't always mean gastric cancer, but if they persist or keep coming back, don't ignore them. Speak to your doctor.
This #GCAM2026, learn to recognise the signs.
November 1, 2026 at 9:01 AM
Symptoms of #GastricCancer can be vague and are often mistaken for less serious conditions.
These symptoms don't always mean gastric cancer, but if they persist or keep coming back, don't ignore them. Speak to your doctor.
This #GCAM2026, learn to recognise the signs.
These symptoms don't always mean gastric cancer, but if they persist or keep coming back, don't ignore them. Speak to your doctor.
This #GCAM2026, learn to recognise the signs.
#Takeda has reported positive results from its phase 3 G-HOPE-001 trial of anti-CLDN18.2 drug arcotatug #tavatecan (TAK-921) in advanced #gastriccancer, setting up its first #regulatory filing outside China.
pharmaphorum.com/news/esmo26-...
pharmaphorum.com/news/esmo26-...
October 23, 2026 at 2:28 PM
#Takeda has reported positive results from its phase 3 G-HOPE-001 trial of anti-CLDN18.2 drug arcotatug #tavatecan (TAK-921) in advanced #gastriccancer, setting up its first #regulatory filing outside China.
pharmaphorum.com/news/esmo26-...
pharmaphorum.com/news/esmo26-...
🧬 Salivary SLC5A5 shows promise for early #GastricCancer detection
🔸SLC5A5 was consistently dysregulated in tissue and saliva
🔸Salivary SLC5A5 + age + sex reached 82% sensitivity
Read the article in UEG Journal:
👉 https://bit.ly/4xcbiE4
🔸SLC5A5 was consistently dysregulated in tissue and saliva
🔸Salivary SLC5A5 + age + sex reached 82% sensitivity
Read the article in UEG Journal:
👉 https://bit.ly/4xcbiE4
October 23, 2026 at 5:15 AM
🧬 Salivary SLC5A5 shows promise for early #GastricCancer detection
🔸SLC5A5 was consistently dysregulated in tissue and saliva
🔸Salivary SLC5A5 + age + sex reached 82% sensitivity
Read the article in UEG Journal:
👉 https://bit.ly/4xcbiE4
🔸SLC5A5 was consistently dysregulated in tissue and saliva
🔸Salivary SLC5A5 + age + sex reached 82% sensitivity
Read the article in UEG Journal:
👉 https://bit.ly/4xcbiE4
What drives aggressive #GastricCancer progression?
Hes6 activates PI3K/AKT signaling and stabilizes Twist1, promoting tumour progression and #EpithelialMesenchymalTransition, making it a potential #TherapeuticTarget.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Hes6 activates PI3K/AKT signaling and stabilizes Twist1, promoting tumour progression and #EpithelialMesenchymalTransition, making it a potential #TherapeuticTarget.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
October 20, 2026 at 11:30 PM
What drives aggressive #GastricCancer progression?
Hes6 activates PI3K/AKT signaling and stabilizes Twist1, promoting tumour progression and #EpithelialMesenchymalTransition, making it a potential #TherapeuticTarget.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Hes6 activates PI3K/AKT signaling and stabilizes Twist1, promoting tumour progression and #EpithelialMesenchymalTransition, making it a potential #TherapeuticTarget.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Can a simple blood-based marker help predict #PeritonealMetastasis in #GastricCancer?
A study of 745 patients found low preoperative #AlbuminFibrinogenRatio (AFR) predictive, with combined models achieving AUCs of 0.759 and 0.801.
#currentmedicalscience: doi.org/10.1007/s115...
A study of 745 patients found low preoperative #AlbuminFibrinogenRatio (AFR) predictive, with combined models achieving AUCs of 0.759 and 0.801.
#currentmedicalscience: doi.org/10.1007/s115...
October 20, 2026 at 2:15 PM
Can a simple blood-based marker help predict #PeritonealMetastasis in #GastricCancer?
A study of 745 patients found low preoperative #AlbuminFibrinogenRatio (AFR) predictive, with combined models achieving AUCs of 0.759 and 0.801.
#currentmedicalscience: doi.org/10.1007/s115...
A study of 745 patients found low preoperative #AlbuminFibrinogenRatio (AFR) predictive, with combined models achieving AUCs of 0.759 and 0.801.
#currentmedicalscience: doi.org/10.1007/s115...
Zanidatamab plus chemotherapy, both with and without tislelizumab, led to longer progression-free survival than trastuzumab plus chemotherapy.
🍋 𝗪𝗮𝗻𝘁 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 ? Find it on the Juisci app : s.juisci.com/G7muyQJ
#Oncology #Gastroenterology #GastricCancer #RCT #NEJM
🍋 𝗪𝗮𝗻𝘁 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 ? Find it on the Juisci app : s.juisci.com/G7muyQJ
#Oncology #Gastroenterology #GastricCancer #RCT #NEJM
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer • Juisci
This open-label, phase 3 randomized controlled trial involving patients with HER2-positive advanced gastroesophageal adenocarcinoma demonstrated that zanidatamab plus chemotherapy, with or without tis
s.juisci.com
October 20, 2026 at 6:03 PM
Zanidatamab plus chemotherapy, both with and without tislelizumab, led to longer progression-free survival than trastuzumab plus chemotherapy.
🍋 𝗪𝗮𝗻𝘁 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 ? Find it on the Juisci app : s.juisci.com/G7muyQJ
#Oncology #Gastroenterology #GastricCancer #RCT #NEJM
🍋 𝗪𝗮𝗻𝘁 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 ? Find it on the Juisci app : s.juisci.com/G7muyQJ
#Oncology #Gastroenterology #GastricCancer #RCT #NEJM
#Autophagy may help overcome #CisplatinResistance in #GastricCancer.
This review explores autophagy’s role in tumor survival and death, highlighting drugs and emerging targets that could restore cisplatin sensitivity.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review explores autophagy’s role in tumor survival and death, highlighting drugs and emerging targets that could restore cisplatin sensitivity.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
October 17, 2026 at 12:30 AM
#Autophagy may help overcome #CisplatinResistance in #GastricCancer.
This review explores autophagy’s role in tumor survival and death, highlighting drugs and emerging targets that could restore cisplatin sensitivity.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This review explores autophagy’s role in tumor survival and death, highlighting drugs and emerging targets that could restore cisplatin sensitivity.
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
For localized deficient mismatch repair or microsatellite instability–high #GastricCancer and gastroesophageal junction adenocarcinoma, neoadjuvant nivolumab plus ipilimumab followed by adjuvant nivolumab was associated with sustained long-term survival.
ja.ma/4ex2nGw
ja.ma/4ex2nGw
October 15, 2026 at 3:30 PM
For localized deficient mismatch repair or microsatellite instability–high #GastricCancer and gastroesophageal junction adenocarcinoma, neoadjuvant nivolumab plus ipilimumab followed by adjuvant nivolumab was associated with sustained long-term survival.
ja.ma/4ex2nGw
ja.ma/4ex2nGw
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/47Pt0CO
ja.ma/47Pt0CO
October 13, 2026 at 11:00 AM
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/47Pt0CO
ja.ma/47Pt0CO
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/4jP315G
ja.ma/4jP315G
October 10, 2026 at 11:00 AM
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/4jP315G
ja.ma/4jP315G
ENO1 connects #Glycolysis with #GastricCancer stemness by regulating ATP pools and lactate homeostasis, which coordinate AMPK/mTOR and PI3K/AKT signaling to promote EMT, self-renewal, migration, and invasion.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerStemness
#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerStemness
October 9, 2026 at 6:30 AM
ENO1 connects #Glycolysis with #GastricCancer stemness by regulating ATP pools and lactate homeostasis, which coordinate AMPK/mTOR and PI3K/AKT signaling to promote EMT, self-renewal, migration, and invasion.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerStemness
#STTT #OpenAccess: doi.org/10.1038/s413...
#CancerStemness
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/47pUOxL
ja.ma/47pUOxL
October 7, 2026 at 4:42 PM
Among patients with #GastricCancer and positive peritoneal lavage cytology or localized peritoneal metastasis, #chemotherapy plus #gastrectomy was associated with better survival than gastrectomy alone or chemotherapy alone.
ja.ma/47pUOxL
ja.ma/47pUOxL
First patient enrolled in COMPASSION-37, Akeso's global Phase 3 of cadonilimab in first-line HER2-negative gastric cancer. Comparator: chemotherapy with or without nivolumab.
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
October 1, 2026 at 1:03 AM
First patient enrolled in COMPASSION-37, Akeso's global Phase 3 of cadonilimab in first-line HER2-negative gastric cancer. Comparator: chemotherapy with or without nivolumab.
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
#GastricCancer #Biotech #Oncology
Disclaimer: This is NOT a financial advice
Keynote speaker Dr. Parry Guilford breaks down the similarities between #lobular #breastcancer and diffuse #gastriccancer via a hereditary #CDH1 mutation. #ILCSymposium. Good to know as we enter Hereditary Cancer Awareness Week! #bcsm @lobularbca.bsky.social
September 24, 2026 at 6:45 PM
Keynote speaker Dr. Parry Guilford breaks down the similarities between #lobular #breastcancer and diffuse #gastriccancer via a hereditary #CDH1 mutation. #ILCSymposium. Good to know as we enter Hereditary Cancer Awareness Week! #bcsm @lobularbca.bsky.social
Mitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
September 24, 2026 at 2:54 PM
Mitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
Guilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm
September 24, 2026 at 7:02 PM
Guilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm
Could metal nanoparticles overcome the limitations holding back early #GastricCancer detection?
#MetalNanoparticles (MNPs) paired with imaging, biosensors, liquid biopsy and #AI could boost biomarker detection and diagnostic accuracy.
#NanotechnologyReviews: doi.org/10.1515/ntre...
#MetalNanoparticles (MNPs) paired with imaging, biosensors, liquid biopsy and #AI could boost biomarker detection and diagnostic accuracy.
#NanotechnologyReviews: doi.org/10.1515/ntre...
September 18, 2026 at 2:45 AM
Could metal nanoparticles overcome the limitations holding back early #GastricCancer detection?
#MetalNanoparticles (MNPs) paired with imaging, biosensors, liquid biopsy and #AI could boost biomarker detection and diagnostic accuracy.
#NanotechnologyReviews: doi.org/10.1515/ntre...
#MetalNanoparticles (MNPs) paired with imaging, biosensors, liquid biopsy and #AI could boost biomarker detection and diagnostic accuracy.
#NanotechnologyReviews: doi.org/10.1515/ntre...